Founded in 2020, AcuSurgical is a surgical robotics company based in France. AcuSurgical's mission is to enable top-class treatment to the 300+ million patients suffering from retinal disease worldwide.
Retinal disease has a huge impact on the quality of life of mostly elderly patients, with 1 in 3 Europeans over 70 affected by these debilitating conditions including age-related macular degeneration (AMD), diabetic retinopathy and macular holes. Worldwide, currently 1.6 million retinal surgeries are performed each year, with a yearly growth rate of 7%. This currently represents only a small percentage of actual cases, with the majority of patients, especially in emerging economies, getting inadequate treatment or often no treatment at all.
The cutting-edge robotics platform from AcuSurgical aims to change this, bringing a new surgical paradigm to vitreo-retinal surgery based on precision robotics.
Financing round - Series A
Number of Employees